The company reported an 18.7% y-o-y growth in profits
Chennai, November 8th 2017:TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized domain intensive services provider in Life Sciences and Supply Chain Management, today announced its financial results for Q2 FY18. The Company carried forward the momentum witnessed in Q1 FY18, reporting strong Q2 revenue and profit figures of INR 3,709 Mn and INR 374 Mn. respectively as it progressed along its 5-year transformational scale up journey to emerge as a significantly larger enterprise.
Last quarter, the Company announced the consolidation of its specialized Life Sciences brands Navitas (technology-led Life Sciences services provider across Clinical, Regulatory and Safety), Ecron Acunova (CRO with Clinical and BA/BE capabilities) and Intelent (Big Data Analytics expert) as Navitas Life Sciences, an end-to-end provider of transformative services offering a full-service coverage of the Pharma and Biotech R&D market. The success of this go-to-market strategy stands validated by the 17.96% y-o-y growth in Life Sciences revenue.
In recognition of its internal processes, structure and governance best practices, TAKE was bestowed with the Golden Peacock Awards for Excellence in Corporate Governance by the prestigious Institute of Directors at their international convention of global leaders at London.
Mr. Srinivasan HR, Vice Chairman and Managing Director, TAKE Solutions said, “The successful integration of the complimentary, niche capabilities of our legacy brands as Navitas Life Sciences continues to register tremendously positive business impact as witnessed by our consistently strong performances and prestigious industry recognitions. We are in a very promising position to penetrate new markets and further capitalize on global opportunities as we move closer to achieving the growth target envisioned in our transformational scale-up initiative.”
About TAKE Solutions
TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management.
In the fast-growing Life Sciences space, TAKE offers clients a unique combination of a full-service CRO backed by industry insights and technology expertise. Our range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through our proprietary industry networks. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers outcomes for clients, including 9 of the top 10 global pharmaceutical companies.
In Supply Chain Management, TAKE focuses on high-margin niches in engineering, mobility and collaboration. Our IP-led approach enables our clients to automate supply chain processes, track, trace & control at item level, extend mobility, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes.
With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange. Led by a team of industry stalwarts and domain experts, TAKE has been growing steadily with FY17 revenues touching INR 13,520 Mn, a 29% increase year-on-year.
For more information, please visit www.takesolutions.com.
Contacts::
Samhita Suresh, TAKE Solutions, +91 44 66110700, This email address is being protected from spambots. You need JavaScript enabled to view it.
Jayeeta Chowdhury, 20:20 MSL, +91 9962750769, This email address is being protected from spambots. You need JavaScript enabled to view it.
